Pituitary adenylate cyclase‐activating peptide: Potential roles in the pathophysiology and complications of cirrhosis-Reference-Cited by-同舟云学术

Pituitary adenylate cyclase‐activating peptide: Potential roles in the pathophysiology and complications of cirrhosis

Published:2020-07-26 Issue:11 Volume:40 Page:2578-2589
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int.

Author:

Barloese Mads¹^ORCID,Chitgar Mohammadnavid¹,Hannibal Jens²,Møller Søren¹^ORCID

Affiliation:

1. Department of Clinical Physiology and Nuclear Medicine Center for Functional and Diagnostic Imaging and Research Faculty of Health Sciences Hvidovre Hospital University of Copenhagen Hvidovre Denmark

2. Department of Clinical Biochemistry Bispebjerg Frederiksberg HospitalUniversity of Copenhagen Copenhagen Denmark

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14602

Reference147 articles.

1. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

2. The burden of liver disease in Europe: A review of available epidemiological data

3. Deaths: preliminary data for 2011;Hoyert DL;Natl Vital Stat Rep,2012

4. Liver cirrhosis

5. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment;Cells;2023-11-17

2. Decreased Plasma Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Levels are Linked with Disease Severity in Patients with Liver Cirrhosis;International Journal of Peptide Research and Therapeutics;2021-01-29